Sharon Srebro

400 total citations
9 papers, 311 citations indexed

About

Sharon Srebro is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sharon Srebro has authored 9 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Pulmonary and Respiratory Medicine and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in Sharon Srebro's work include Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (8 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Sharon Srebro is often cited by papers focused on Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (8 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Sharon Srebro collaborates with scholars based in United States. Sharon Srebro's co-authors include Lisa Edwards, Chris Kalberg, Kathy Rickard, Kathleen Rickard, Gordon Raphael, Stanley P. Galant, Bruce Friedman, Eli O. Meltzer, Richard F. Lockey and William E. Berger and has published in prestigious journals such as CHEST Journal, The American Journal of Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Sharon Srebro

8 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon Srebro United States	7	300	265	44	38	16	9	311
Tom Uryniak United States	9	326 1.1×	314 1.2×	43 1.0×	27 0.7×	19 1.2×	25	407
María del Carmen Vennera Spain	9	261 0.9×	203 0.8×	113 2.6×	14 0.4×	9 0.6×	14	291
C. Bucca Italy	3	228 0.8×	182 0.7×	46 1.0×	13 0.3×	19 1.2×	3	270
Paula Corcuera Spain	8	110 0.4×	131 0.5×	9 0.2×	11 0.3×	16 1.0×	26	161
António Bugalho‐Almeida Portugal	8	232 0.8×	152 0.6×	136 3.1×	4 0.1×	16 1.0×	8	296
E. D. Bateman France	6	98 0.3×	81 0.3×	11 0.3×	15 0.4×	9 0.6×	6	129
Ove Hansen Denmark	3	185 0.6×	188 0.7×	18 0.4×	22 0.6×	9 0.6×	5	236
Ola Beckman Sweden	9	338 1.1×	408 1.5×	26 0.6×	12 0.3×	10 0.6×	14	504
Jussi Haanpää Finland	5	275 0.9×	242 0.9×	26 0.6×	3 0.1×	13 0.8×	8	331
Iida Vähätalo Finland	8	147 0.5×	122 0.5×	27 0.6×	4 0.1×	9 0.6×	22	184

Countries citing papers authored by Sharon Srebro

Since Specialization

Citations

This map shows the geographic impact of Sharon Srebro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Srebro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Srebro more than expected).

Fields of papers citing papers by Sharon Srebro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Srebro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Srebro. The network helps show where Sharon Srebro may publish in the future.

Co-authorship network of co-authors of Sharon Srebro

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Srebro. A scholar is included among the top collaborators of Sharon Srebro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Srebro. Sharon Srebro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Meltzer, Eli O., Richard F. Lockey, Bruce Friedman, et al.. (2002). Efficacy and Safety of Low-Dose Fluticasone Propionate Compared With Montelukast for Maintenance Treatment of Persistent Asthma. Mayo Clinic Proceedings. 77(5). 437–445. 33 indexed citations

2.

Clifford, Dennis P., Edward Kerwin, Gordon Raphael, et al.. (2002). Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma. The American Journal of Medicine. 113(1). 15–21. 18 indexed citations

3.

Meltzer, Eli O., Richard F. Lockey, Bruce Friedman, et al.. (2002). Efficacy and Safety of Low-Dose Fluticasone Propionate Compared With Montelukast for Maintenance Treatment of Persistent Asthma. Mayo Clinic Proceedings. 77(5). 437–445. 23 indexed citations

4.

Raphael, Gordon, Stanley P. Galant, Chris Kalberg, et al.. (2001). Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial. Journal of Allergy and Clinical Immunology. 107(3). 461–468. 119 indexed citations

5.

Stoloff, Stuart, Sharon Srebro, Lisa Edwards, Margaret Johnson, & Kathy Rickard. (2001). Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.. PubMed. 3(3). 2–2. 2 indexed citations

6.

Busse, William W., John H. Wolfe, William W. Storms, et al.. (2001). Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.. PubMed. 50(7). 595–602. 37 indexed citations

7.

Ginchansky, Elliot, Bruce Friedman, Sharon Srebro, et al.. (2000). Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy. Annals of Allergy Asthma & Immunology. 85(5). 398–406. 32 indexed citations

8.

Baraniuk, James N., John Murray, Robert A. Nathan, et al.. (1999). Fluticasone Alone or in Combination With Salmeterol vs Triamcinolone in Asthma. CHEST Journal. 116(3). 625–632. 45 indexed citations

9.

Matz, Jonathan, et al.. (1998). Greater improvement in asthma control with fluticasone propionate than with either zafirlukast or placebo. CHEST Journal. 114. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact